Business Context and Reporting Period
This Form 6-K filing by Genmab A/S covers the month of June 2026, with a specific reporting date of June 15, 2026. The document serves as a report of a foreign private issuer pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934. The primary purpose of this filing is to disclose a Major Shareholder Announcement and an Orbis Shareholder Notification, rather than to report operational or financial performance.
Key Financial Metrics
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure regarding shareholder ownership changes and does not contain financial statements or operational metrics.
Material Changes
The material change disclosed in this filing relates to shareholder ownership. The filing includes:
- A Company Announcement dated June 15, 2026, regarding a Major Shareholder.
- An Orbis Shareholder Notification.
No material changes to financial performance or business operations are detailed in this specific text.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, specific risks, contingencies, or unusual items related to operations. The document is strictly limited to the notification of shareholder events.
Investor Verification Checklist
- Verify the specific identity of the major shareholder and the nature of the transaction (e.g., acquisition, disposal, or threshold crossing) referenced in Exhibit 99.1.
- Review the Orbis Shareholder Notification (Exhibit 99.2) for details on the reporting entity and the extent of the holding.
- Check subsequent filings for any impact this shareholder change may have on corporate governance or strategic direction.